Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Ultrasound-Guided Injection Techniques for Shoulder Impingement Syndrome
NCT05015322Phase 4Completed
- Start
- Jan 2017
- Primary completion
- Jan 2021
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, single-blind trial of bupivacaine and methylprednisolone in shoulder impingement syndrome (SIS) (3 arms). Primary endpoint: Visual Analogue Scale at 6 months. Started Jan 2017; status: completed.
02
Drugs
bupivacainemethylprednisolone
03
Conditions
shoulder impingement syndrome (SIS)
Beyond the preview
Go deeper on NCT05015322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05015322.